“I worry that history will judge this as having over-invested in one treatment pathway as opposed to looking more broadly at a larger number of treatment candidates,” School of Public Health at the University at Albany dean David Holtgrave, who co-authored a study on hydroxychloroquine and coronavirus, told CNN.
U.S. left with 63 million doses of hydroxychloroquine after FDA rules it doesn’t help against coronavirus

Prepare Now Before its too Late
Discover where products are available & compare prices